SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Kevin Clarke who wrote (4196)	9/23/1998 12:08:00 AM
From: Prospector	of 5402

I think Dr DREES pretty well gave away the answers tonight.. he said the only problem was to keep the molecules separated to carry oxygen.. plain and simple.. the older formula had too many additives to make it more like blood... so if he can make it simple with only two compounds and still carry oxygen.. ther ya go... less problems.. 3 year shelf life without refridgeration no cross matchin 1/900 the size of a blood cell.. this is what makes it good for restricted blood vessals.. make the cells that are starved for oxygen get enriched.. and on and on and on.... I'm Sold Prospector

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next